A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4 deficient C57BL/6 mice and BALB/c mice

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 4822-4830

  Falcone, Marika ^a,b   Rajan, Alice J ^a   Bloom, Barry R ^a   Brosnan, Celia F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BRAIN; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; TH2 CELLS;

EID: 0032525044     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Williams, K. C., E. Ulvested, and W. F. Hickey. 1994. Immunology of multiple sclerosis. Clin. Neurosci. 2:229.
2. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299.
3. Ebers, G. C., A. D. Sadovnick, and N. J. Risch. 1995. The Canadian Collaborative Study Group. A full genome search in multiple sclerosis. Nature 377:150.
4. Raine, C. S., L. B. Barnett, A. Brown, T. Behar, and D. E. McFarlin. 1980. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:150.
5. Linthicum, D. S., and J. A. Frelinger. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 155:31.
6. Tuohy, V. K., R. A. Sobel and M. B. Lees. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J. Immunol. 140-1868.
7. Endoh, M., T. Kunishita, J. Nihei, M. Nishizawa, and T. Tabira. (1990) Susceptibility to proteolipid apoprotein and its encephalitogenic determinant in mice. Int. Arch. Allergy Appl. Immunol. 92:433.
8. Fritz, R. B., M. J. Skeen, C. H. Chou, M. Garcia, and I. K. Egorov. 1985. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 134:2328.
9. Sundvall, M. J. Jirholt, H-T. Yang, L. Jansson, A. Engstrom, U. Pettersson, and R. Holmdahl. 1995. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nature Genet. 10:313.
10. Encinas, J. A., M. B. Lees, R. A. Sobel, C. Symonowicz, J. M. Greer, C. L. Shovlin, H. L. Weiner, C. E. Seidman, J. G. Seidman, and V. K. Kuchroo. 1996. Genetic analysis of susceptibility to experimental allergic encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157:2186.
11. Baker, D., O. A. Rosenwasser, J. K. O'Neill, and J. L. Turk. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155:4046.
12. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 92:1193.
13. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989.
14. +CD4-CD8-T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46:572.
15. + Tcells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1:34.
16. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin Ag-specific T cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245.
17. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis, Science 265:1237.
18. Miller, A., A. Al-Sabbagh, L. M. B. Santos, M. Prabhu Das, and H. L. Weiner. 1993. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151:7307.
19. Racke, M. K., D. Burnett, S. H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, and D. E. Scott. 1995. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J. Immunol. 154:450.
20. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathway: application to autoimmune disease therapy. Cell 80:707.
21. Saoudi, A., S. Simmonds, I. Huitinga, and D. Mason. 1995. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 182:335.
22. Chen, Y., J-I. Inobe, V. K. Kuchroo, J. L. Baron, C. A. Janeway, and H. L. Weiner. 1996. Oral tolerance in myelin basic protein T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 93:388.
23. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis. J. Immunol. 156:5.
24. Willenborg, D. O., S. Fordham, C. C. A. Bernard, W. B. Cowden, and I. A. Ramshaw. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223.
25. Frei, K., H. P. Eugster, M. Bopst, C. S. Constantinescu, E. Lavi, and A. Fontana. 1997. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis, J. Exp. Med. 185:2177.
26. LaFaille, J. J., F. van de Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1991. Myelin basic protein specific Th2 cells cause experimental autoimmune encephalomyelitis in immunodeficiem hosts rather than protecting them from the disease. J. Exp. Med. 186:307.
27. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093.
28. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, L. Steinman, G. P. Nolan, and C. G. Fathman. 1997. Local delivery of IL-4 by retro virus-transduced T lymphocytes ameliorates experimental allergic encephalomyelitis. J. Exp. Med. 185:1711.
29. Falcone, M., and B. R. Bloom. 1997. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:901.
30. Norton, W. T., and S. E. Poduslo. 1973. Myelin in rat brain: method of myelin isolation. J. Neurochem. 21:749.
31. Rajan, A. J., Y-L. Gao, C. S. Raine, and C. F. Brosnan. 1996. A pathogenic role for -γδ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL/J mouse. J. Immunol 157:941.
32. + T cells from young and old mice. J. Immunol. 150:3602.
33. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental allergic encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
34. Crisi, G. M., L. Santambrogio, G. M Hochwald, S. R. Smith, J. A. Carlino, and G. J. Thorbecke. 1995. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur. J. Immunol. 25:3035.
35. + cells: new clues to their origin, specificity and function. J. Exp. Med. 182:633.
36. + T cells in a Th2 response and in immunoglobulin E production. Science 270:1845.
37. Segal, B. M., and E. M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:771.
38. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
39. Le Gros, G., S. Z. Ben-Sasson, R. A. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin-4 (IL-4)-producing cells in vivo and in vitro. IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172:921.
40. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
41. Liblau, R., L. Steinman, and S. Brocke. 1997. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol. 9:799.
42. Gerosa, F., C. Paganin, D. Peritt, F. Paiola, M. T. Scupoli, M. Aste-Amezaga, I. Frank, and G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J. Exp. Med. 183:2559.
43. Meyaard, L., E. Hovenkamp, S. A. Otto, and F. Miedema. 1996. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156:2776.